State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2018-2022

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.8 to 9.9 and 21,112 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Iowa⁷

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 11.8 to 13.2 and 267 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 5)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 11.5 with a 95% confidence interval from 10.9 to 12.1 and 287 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 17)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 11.4 with a 95% confidence interval from 10.9 to 11.9 and 453 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 15)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 11.2 with a 95% confidence interval from 10.7 to 11.8 and 333 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 20)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 11.2 with a 95% confidence interval from 10.2 to 12.2 and 120 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (1, 31)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 11.1 with a 95% confidence interval from 10.6 to 11.6 and 406 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (2, 21)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 11.1 with a 95% confidence interval from 9.8 to 12.4 and 61 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (1, 36)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 10.9 with a 95% confidence interval from 10.4 to 11.4 and 452 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (2, 24)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 10.9 with a 95% confidence interval from 10.6 to 11.2 and 1,019 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (3, 20)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 10.8 with a 95% confidence interval from 10.5 to 11.2 and 869 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (3, 21)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 10.8 with a 95% confidence interval from 10.0 to 11.7 and 145 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (2, 33)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 10.7 with a 95% confidence interval from 9.7 to 11.9 and 83 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (1, 37)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 10.7 with a 95% confidence interval from 9.8 to 11.6 and 120 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (2, 34)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 10.6 with a 95% confidence interval from 9.3 to 12.1 and 53 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (1, 40)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 10.6 with a 95% confidence interval from 9.7 to 11.6 and 105 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (2, 36)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 10.6 with a 95% confidence interval from 10.4 to 10.9 and 1,434 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (7, 24)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.0 to 11.1 and 312 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (3, 32)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.3 to 10.7 and 1,695 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (9, 26)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 10.4 with a 95% confidence interval from 10.1 to 10.8 and 651 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (8, 30)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 10.4 with a 95% confidence interval from 8.8 to 12.1 and 36 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (1, 44)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 10.3 with a 95% confidence interval from 10.0 to 10.7 and 852 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (11, 31)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 10.3 with a 95% confidence interval from 9.8 to 10.7 and 446 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (8, 33)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.8 to 10.5 and 693 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (12, 33)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.7 to 10.6 and 483 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (11, 34)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.7 to 10.5 and 481 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (11, 34)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.7 to 10.4 and 693 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (13, 33)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 8.8 to 11.5 and 47 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (1, 44)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.4 to 10.8 and 188 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (7, 37)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 9.9 with a 95% confidence interval from 8.9 to 11.0 and 74 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (3, 42)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 9.9 with a 95% confidence interval from 9.3 to 10.5 and 246 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (11, 38)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.0 to 10.7 and 119 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (7, 41)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.7 to 10.0 and 2,323 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (23, 34)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 9.7 with a 95% confidence interval from 9.0 to 10.4 and 148 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (11, 41)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 9.0 to 9.7 and 597 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (27, 39)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.2 to 10.4 and 67 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (9, 46)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.6 to 9.7 and 260 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (27, 43)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.7 to 9.6 and 370 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (30, 42)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.6 to 9.5 and 307 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (30, 43)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.3 to 9.5 and 179 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (29, 46)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.5 to 9.0 and 1,385 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (36, 44)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.2 to 9.0 and 387 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (35, 46)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 8.4 with a 95% confidence interval from 8.0 to 8.7 and 460 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (37, 46)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 8.1 with a 95% confidence interval from 6.8 to 9.6 and 29 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (17, 51)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.6 to 8.5 and 287 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (40, 48)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.4 to 8.6 and 154 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (38, 49)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.2 to 8.8 and 83 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (35, 50)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.2 to 8.0 and 366 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (43, 49)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.1 to 8.6 and 27 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (35, 51)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 7.0 with a 95% confidence interval from 6.6 to 7.5 and 239 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (46, 51)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.2 to 7.4 and 97 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (45, 51)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 6.1 to 7.2 and 127 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (47, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.0 to 4.8 and 108 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/22/2026 11:42 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.